Sun Zhongjie
Department of Medicine, University of Florida, Gainesville, FL, USA.
Methods Mol Med. 2005;112:3-12. doi: 10.1385/1-59259-879-x:003.
Molecular cardiology is a new area of cardiovascular medicine that aims to apply molecular biological techniques for the mechanistic investigation, diagnosis, prevention, and treatment of cardiovascular disease. As an emerging discipline, it has changed our conceptual thinking of cardiovascular development, disease etiology, and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. With the rapid development and application of molecular biological techniques, scientists and clinicians are closer to curing heart diseases that were thought to be incurable 20 yr ago. There clearly is a need for a more thorough understanding of the molecular mechanisms of cardiovascular diseases to promote the advancement of cell and gene therapy for heart diseases. This chapter briefly reviews state-of-the-art techniques in the area of molecular cardiology.
分子心脏病学是心血管医学的一个新领域,旨在应用分子生物学技术对心血管疾病进行机制研究、诊断、预防和治疗。作为一门新兴学科,它改变了我们对心血管发育、疾病病因和病理生理学的概念性认识。尽管分子心脏病学仍处于非常早期的阶段,但它为理解和控制心血管疾病开辟了一条充满希望的途径。随着分子生物学技术的迅速发展和应用,科学家和临床医生离治愈20年前被认为无法治愈的心脏病更近了一步。显然,需要更深入地了解心血管疾病的分子机制,以推动心脏病细胞和基因治疗的进展。本章简要回顾分子心脏病学领域的最新技术。